The importance of partnership: A conversation with Takeda

Strategic partnerships within the biopharmaceutical industry are key to accelerating the process of getting medicines to patients. I recently sat down with Pallavi Garg, Head of the U.S. Oncology Business Unit at Takeda, to explore how collaboration in our industry is driving progress in the fight against cancer.

Our discussion highlights how Takeda's partnerships are not just addressing unmet needs in oncology, but also breaking down barriers to innovation. These efforts align with our industry's goal: ensuring groundbreaking medicines reach patients when they need them most.

Watch the video to learn more about Takeda's patient-centric approach to shaping the future of oncology research.